<DOC>
	<DOCNO>NCT00878228</DOCNO>
	<brief_summary>The study randomize placebo control trial determine whether repeat postoperative prophylactic ondansetron ( `` Zofran '' ) administration prevent postoperative and/or postdischarge nausea vomit patient undergo ambulatory hip arthroscopy . Ondansetron administer intra- post-operative period . These individual follow postoperative day 1 , 2 , 3 . It hypothesize incidence postdischarge nausea vomit ( PDNV ) significantly decrease postoperative prophylactic administration multiple dose ondansetron ( Zofran ) .</brief_summary>
	<brief_title>Antiemetic Prophylaxis Postdischarge Nausea Vomiting After Hip Arthroscopy</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Antiemetics</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>All patient Dr. Coleman Dr. Kelly age 18 65 undergoing arthroscopic hip surgery Planned use neuraxial anesthesia Ability follow study protocol Willing complete daily diary interview daily three day discharge Patients young 18 year old old 65 Patients unable undergo spinal epidural anesthetic Having nausea vomit within 24 hour surgery Receiving drug antiemetic property within 24 hour surgery ( e.g Zofran , Compazine , Phenergan , Reglan ) Chronic opioid use ( defined daily almost daily use opioids &gt; 3 month ) Hypersensitivity and/or allergy ondansetron Intraoperative use volatile anesthetic Contraindication short course NSAIDs ( renal failure , intolerance ) Allergy intolerance Vicodin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>